BioCentury | Mar 24, 2014
Strategy

A Remembrance: The quintessential serial entrepreneur

Very few of us will live as long, invent as much, or improve as many lives as Alejandro Zaffaroni. Alex, who was 91 when he passed away this month, already was an eminence grise in...
BC Week In Review | Apr 15, 2013
Company News

Symyx Technologies, Hoechst AG deal

The companies began a long-term research collaboration in which Symyx will apply its combinatorial chemistry technology toward material science applications such as chemical catalysts. Hoechst will spend $10 million on research at Symyx over the...
BioCentury | Oct 15, 2012
Product Development

Gut instinct

Ardelyx Inc. took its gut-specific small molecule approach from concept to Phase II testing in under four years and now has scored a partnership with AstraZeneca plc as the pharma adds diabetic complications as a...
BC Week In Review | Feb 22, 2010
Company News

Symyx deal

Symyx said an undisclosed company will acquire its High Productivity Research ( HPR ) business unit, including its high throughput screening automation tools, for a $10 million loan and a 19.5% equity stake in the acquiring company....
BioCentury | Dec 14, 2009
Finance

Ebb & Flow

Investors in oncology company Gloucester Pharmaceuticals Inc. are looking at a 3.5X-6.5X return on an acquisition by Celgene Corp. (NASDAQ: CELG), making it a model for how to execute in-licensing and keep costs under control....
BioCentury | Jan 19, 2009
Finance

JPMorgan effect

JPMorgan effect Company Day chg Wk chg 1/16 cls ZymoGenetics (NASDAQ:ZGEN) -0.2% 50.5% $4.35 Illumina (NASDAQ:ILMN) 3.8% 29.4% $30.33 Human Genome (NASDAQ:HGSI) -6.8% 28.7% $2.42 CV Therapeutics (NASDAQ:CVTX) 1.9% 20.2% $10.83 Momenta (NASDAQ:MNTA) 5.8% 13.5%...
BC Week In Review | Feb 4, 2008
Company News

Amyris Biotechnologies Inc. management update

Amyris Biotechnologies Inc. , Emeryville, Calif.   Business: Biomanufacturing   Hired: Jeryl Hilleman as CFO, formerly EVP and CFO of Symyx Technologies Inc.  ...
BC Week In Review | Jan 14, 2008
Company News

Relypsa management update

Relypsa Inc. , Santa Clara, Calif.   Business: Metabolic, Cardiovascular, Renal   Hired: Ronald Krasnow as SVP of intellectual property and chief patent counsel, formerly SVP of intellectual property at Symyx Technologies Inc.  ...
BC Week In Review | Nov 5, 2007
Company News

Symyx, Reed Elsevier Group plc deal

SMMX acquired REN's MDL Information Systems Inc. subsidiary for $123 million in cash. MDL develops and markets bioinformatics software and databases for biological research and development, including MDL ISIS and MDL Isentris systems. SMMX will...
BC Week In Review | Nov 5, 2007
Company News

Symyx management update

Symyx Technologies Inc. (SMMX), Santa Clara, Calif.   Business: Chemistry, High throughput screening   Hired: Rex Jackson as CFO; and Gerard Abraham as president of SMMX's Symyx Tools unit  ...
Items per page:
1 - 10 of 121
BioCentury | Mar 24, 2014
Strategy

A Remembrance: The quintessential serial entrepreneur

Very few of us will live as long, invent as much, or improve as many lives as Alejandro Zaffaroni. Alex, who was 91 when he passed away this month, already was an eminence grise in...
BC Week In Review | Apr 15, 2013
Company News

Symyx Technologies, Hoechst AG deal

The companies began a long-term research collaboration in which Symyx will apply its combinatorial chemistry technology toward material science applications such as chemical catalysts. Hoechst will spend $10 million on research at Symyx over the...
BioCentury | Oct 15, 2012
Product Development

Gut instinct

Ardelyx Inc. took its gut-specific small molecule approach from concept to Phase II testing in under four years and now has scored a partnership with AstraZeneca plc as the pharma adds diabetic complications as a...
BC Week In Review | Feb 22, 2010
Company News

Symyx deal

Symyx said an undisclosed company will acquire its High Productivity Research ( HPR ) business unit, including its high throughput screening automation tools, for a $10 million loan and a 19.5% equity stake in the acquiring company....
BioCentury | Dec 14, 2009
Finance

Ebb & Flow

Investors in oncology company Gloucester Pharmaceuticals Inc. are looking at a 3.5X-6.5X return on an acquisition by Celgene Corp. (NASDAQ: CELG), making it a model for how to execute in-licensing and keep costs under control....
BioCentury | Jan 19, 2009
Finance

JPMorgan effect

JPMorgan effect Company Day chg Wk chg 1/16 cls ZymoGenetics (NASDAQ:ZGEN) -0.2% 50.5% $4.35 Illumina (NASDAQ:ILMN) 3.8% 29.4% $30.33 Human Genome (NASDAQ:HGSI) -6.8% 28.7% $2.42 CV Therapeutics (NASDAQ:CVTX) 1.9% 20.2% $10.83 Momenta (NASDAQ:MNTA) 5.8% 13.5%...
BC Week In Review | Feb 4, 2008
Company News

Amyris Biotechnologies Inc. management update

Amyris Biotechnologies Inc. , Emeryville, Calif.   Business: Biomanufacturing   Hired: Jeryl Hilleman as CFO, formerly EVP and CFO of Symyx Technologies Inc.  ...
BC Week In Review | Jan 14, 2008
Company News

Relypsa management update

Relypsa Inc. , Santa Clara, Calif.   Business: Metabolic, Cardiovascular, Renal   Hired: Ronald Krasnow as SVP of intellectual property and chief patent counsel, formerly SVP of intellectual property at Symyx Technologies Inc.  ...
BC Week In Review | Nov 5, 2007
Company News

Symyx, Reed Elsevier Group plc deal

SMMX acquired REN's MDL Information Systems Inc. subsidiary for $123 million in cash. MDL develops and markets bioinformatics software and databases for biological research and development, including MDL ISIS and MDL Isentris systems. SMMX will...
BC Week In Review | Nov 5, 2007
Company News

Symyx management update

Symyx Technologies Inc. (SMMX), Santa Clara, Calif.   Business: Chemistry, High throughput screening   Hired: Rex Jackson as CFO; and Gerard Abraham as president of SMMX's Symyx Tools unit  ...
Items per page:
1 - 10 of 121